Eye care professionals are featured in LENZ Therapeutics' campaign about the common eye condition presbyopia. (Credit: LENZ Therapeutics)
April 5, 2024 02:30 PM EDTUpdated 02:58 PM
Pharma
Marketing

LENZ ral­lies pres­by­opia aware­ness with eye­care pro­fes­sion­als ahead of FDA sub­mis­sion

Beth Snyder Bulik

Senior Editor

LENZ Ther­a­peu­tics is clear on the ben­e­fits of pre-com­mer­cial mar­ket­ing for its pres­by­opia eye drops, bol­stered by pos­i­tive Phase 3 news this week. The new …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times